089P London, UK
Pharmacology 2017

 

 

A cannabis extract and morphine: increased analgesia without increased respiratory depression

K. Taheri, J. Padam, C. Bayley, B. A. MacLeod, E. Puil. Anesthesiology, Pharmacology, & Therapeutics, University of British Columbia, Vancouver, Canada.

Introduction: Δ9-Tetrahydrocannabinol (THC), a major psychoactive component of cannabis, enhances the thermal analgesic properties of morphine1. Studies have also shown possible potentiated effects of THC using combinations of different cannabinoids2. Therefore, we aimed to study the thermal analgesic properties and respiratory effects of cannabis extract in combination with morphine.

Methods: Cannabis extract was prepared from cannabis flowers using hexane liquid-liquid extraction in vehicle (18:1:1 saline: ethanol: ethoxylated castor oil). The cannabinoid content was quantified using HPLC. Morphine was dissolved in saline. Adult female CD1 mice (25-30 g) were randomly assigned to treatment groups. Animals were injected intravenously with extract (0-0.8 mg/kg THC; n = 5/group), morphine (0.2-12 mg/kg; n = 8), extract (0-0.8 mg/kg THC) and 6 mg/kg morphine (n = 8), or saline (n = 8). Mice were habituated to their environment for 60 min prior to pre- and post-treatment tests. Thermal stimulus response was measured using a ramped hotplate3 with a temperature range of 32.1°C to 52.1°C. Withdrawal latencies were measured at 5 min after treatment. Mice were then placed in modified Falcon tubes and videotaped for 10 min. Respiratory rate (min-1) was measured during the 9-10th min interval (19-20 minutes after treatment). ANOVA or Kurskal-Wallis followed by Dunnett’s or Dunn’s multiple comparison test was performed (α = 0.01) as appropriate. Delta latencies were calculated by subtracting pre-treatment from post-treatment latencies. Data are shown as mean with SD.

Results: Extract did not affect withdrawal latency or respiratory rate at any dose tested (P > 0.01 compared to vehicle). Compared to saline, morphine increased latency at 6 and 12 mg/kg (-0.4±6.7 s vs. 36.8±18.3, 60.4±19.3 s; P = 0.0009, <0.0001) and decreased respiratory rate at 1-12 mg/kg (186±19 min-1 vs. 147±15, 125±17, 125±17 min-1; P = 0.0063, 0.0001, 0.0001). Significant increases in delta latency were seen between 6 mg/kg morphine with vehicle, and combinations of 0.2, 0.4, and 0.8 mg/kg extract and 6 mg/kg morphine (20.0±8.9 s vs. 54.8.8±21.5, 66.8±8.6, 64.9±13.3 s; P = 0.0005, 0.0001, 0.0001) without increased respiratory depression (132±15 min-1 vs. 122±16, 111±13, 119±24 min-1; P= 0.77, 0.16, 0.59).

Conclusion: Non-analgesic doses of a cannabis extract combined with a fixed dose of morphine produced an increase in thermal analgesia without added respiratory depression.

References:

1. Smith F et al. (1998). J Pharmacol Exp Ther 60(2): 559-566.

2. Karniol IG and Carlini EA (1973). Psychopharmacologia 33(1): 53

3. Hunskaar S et al. (1986). Behav Brain Res 21(2): 101